United States · FDA National Drug Code directory
Raloxifene hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72241-010_f0db29f5-28da-4165-94f8-24727b6b71e5
- Product NDC
- 72241-010
- Form
- TABLET, COATED
- Composition / generic term
- Raloxifene hydrochloride
- Labeler
- Modavar Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171230
- Source listing expiry
- 20261231
Source-listed ingredients
- RALOXIFENE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, COATED in 1 BOTTLE (72241-010-05) · 72241-010-05
- 1000 TABLET, COATED in 1 BOTTLE (72241-010-11) · 72241-010-11
- 2000 TABLET, COATED in 1 BOTTLE (72241-010-13) · 72241-010-13
- 30 TABLET, COATED in 1 BOTTLE (72241-010-22) · 72241-010-22
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →